CASSS WCBP 2025
Washington, DC
Request a meeting with our team in Washington, DC to discuss your project and how we can help you advance your therapeutic drug program.
Presentation
Jeff Patrick, PhD, -Senior Director
Shiqian Zhu, PhD, -Director
Tuesday, January 28, 2025, 12:25-1:25 PM
Location: District Ballroom
Jeff Patrick, PhD, -Senior Director
Shiqian Zhu, PhD, -Director
Tuesday, January 28, 2025, 12:25-1:25 PM
Location: District Ballroom
Jeff Patrick, PhD, -Senior Director
Shiqian Zhu, PhD, -Director
Tuesday, January 28, 2025, 12:25-1:25 PM
Location: District Ballroom
BioAgilytix Presentations at EIP
Jeff Patrick, PhD, -Senior Director
Shiqian Zhu, PhD, -Director
Tuesday, January 28, 2025, 12:25-1:25 PM
Location: District Ballroom
BioAgilytix Presentations at EIP
Jeff Patrick, PhD, -Senior Director
Shiqian Zhu, PhD, -Director
Tuesday, January 28, 2025, 12:25-1:25 PM
Location: District Ballroom
Schedule a meeting with our experts on site
Learn how the combination of world-class scientific expertise, outstanding project management, and key regulatory insight can streamline our support for your therapeutic.
Schedule a meeting with our experts on site
Learn how the combination of world-class scientific expertise, outstanding project management, and key regulatory insight can streamline our support for your therapeutic.
About the event
The WCBP Symposium has established a reputation as one of the highest-regarded annual conferences addressing the role of current and emerging CMC analytical technology among evolving US and international regulatory perspectives. This year, WCBP 2025 will be co-sponsored by the US FDA. Effective communication and intellectual collaboration between regulators and industry leaders around regulatory expectations for applying these new technologies in the CMC space is a critical part of future scientific advancements for drug developers.
Partner with BioAgilytix for CMC analytical testing services for biopharmaceutical product development
BioAgilytix is a global CRO focused on CMC analytical support for biologics and ATMPs from pre-IND to commercial release testing. Since 2008, we have specialized in solving challenging analytical problems and supporting commercial programs. Since 2014, cGMP testing has been available in the US and EU.
We have deep technical expertise in cell-based potency assays, molecular assays, MS characterization, and many other analytical test methodologies, where our consultative science-forward approach leads to the best solutions for our clients.
Schedule a meeting with our experts on site
Learn how the combination of world-class scientific expertise, outstanding project management, and key regulatory insight can streamline our support for your therapeutic.
© Copyright 2025 BioAgilytix Labs. All rights reserved.
Schedule a meeting with our experts on site
Learn how the combination of world-class scientific expertise, outstanding project management, and key regulatory insight can streamline our support for your therapeutic.
© Copyright 2025 BioAgilytix Labs. All rights reserved.